Clinical Trial Update: Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients

View source ↗

Summary

Multicenter trial sponsored by AstraZeneca evaluated whether smoking patterns influence the clinical efficacy of an epidermal growth factor receptor tyrosine ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED